206 related articles for article (PubMed ID: 36284346)
1. Efficacy and safety of carbon ion radiotherapy for bone sarcomas: a systematic review and meta-analysis.
Dong M; Liu R; Zhang Q; Luo H; Wang D; Wang Y; Chen J; Ou Y; Wang X
Radiat Oncol; 2022 Oct; 17(1):172. PubMed ID: 36284346
[TBL] [Abstract][Full Text] [Related]
2. Particle Therapy Using Protons or Carbon Ions for Unresectable or Incompletely Resected Bone and Soft Tissue Sarcomas of the Pelvis.
Demizu Y; Jin D; Sulaiman NS; Nagano F; Terashima K; Tokumaru S; Akagi T; Fujii O; Daimon T; Sasaki R; Fuwa N; Okimoto T
Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):367-374. PubMed ID: 28463156
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of carbon ion radiotherapy for chordomas: a systematic review and meta-analysis.
Dong M; Liu R; Zhang Q; Wang D; Luo H; Wang Y; Chen J; Ou Y; Wang X
Radiat Oncol; 2023 Sep; 18(1):152. PubMed ID: 37705083
[TBL] [Abstract][Full Text] [Related]
4. Clinical Efficacy of Carbon Ion Radiotherapy for Unresectable Chondrosarcomas.
Imai R; Kamada T; Araki N;
Anticancer Res; 2017 Dec; 37(12):6959-6964. PubMed ID: 29187480
[TBL] [Abstract][Full Text] [Related]
5. Carbon ion radiotherapy for skull base chordomas and chondrosarcomas: a systematic review and meta-analysis of local control, survival, and toxicity outcomes.
Lu VM; O'Connor KP; Mahajan A; Carlson ML; Van Gompel JJ
J Neurooncol; 2020 May; 147(3):503-513. PubMed ID: 32206977
[TBL] [Abstract][Full Text] [Related]
6. Homogenous and Heterogenous Prognostic Factors for Patients with Bone Sarcoma.
Xu G; Wu H; Xu Y; Zhang Y; Lin F; Baklaushev VP; Chekhonin VP; Peltzer K; Wang X; Mao M; Wang G; Cui P; Zhang C
Orthop Surg; 2021 Feb; 13(1):134-144. PubMed ID: 33305494
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of proton beam therapy for rhabdomyosarcoma: a systematic review and meta-analysis.
Dong M; Wu J; Wu R; Wang D; Liu R; Luo H; Wang Y; Chen J; Ou Y; Zhang Q; Wang X
Radiat Oncol; 2023 Feb; 18(1):31. PubMed ID: 36805784
[TBL] [Abstract][Full Text] [Related]
8. Outcome and Toxicity of Carbon Ion Radiotherapy for Axial Bone and Soft Tissue Sarcomas.
Cuccia F; Fiore MR; Barcellini A; Iannalfi A; Vischioni B; Ronchi S; Bonora M; Riva G; Vai A; Facoetti A; Preda L; Valvo F; Vitolo V
Anticancer Res; 2020 May; 40(5):2853-2859. PubMed ID: 32366434
[TBL] [Abstract][Full Text] [Related]
9. The preliminary results of proton and carbon ion therapy for chordoma and chondrosarcoma of the skull base and cervical spine.
Guan X; Gao J; Hu J; Hu W; Yang J; Qiu X; Hu C; Kong L; Lu JJ
Radiat Oncol; 2019 Nov; 14(1):206. PubMed ID: 31752953
[TBL] [Abstract][Full Text] [Related]
10. Impact of carbon ion radiotherapy for primary spinal sarcoma.
Matsumoto K; Imai R; Kamada T; Maruyama K; Tsuji H; Tsujii H; Shioyama Y; Honda H; Isu K;
Cancer; 2013 Oct; 119(19):3496-503. PubMed ID: 23939877
[TBL] [Abstract][Full Text] [Related]
11. Intensity-Modulated Proton and Carbon-Ion Radiation Therapy in the Management of Head and Neck Sarcomas.
Yang J; Gao J; Qiu X; Hu J; Hu W; Wu X; Zhang C; Ji T; Kong L; Lu JJ
Cancer Med; 2019 Aug; 8(10):4574-4586. PubMed ID: 31231939
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy in bone sarcoma: the quest for better treatment option.
Locquet MA; Brahmi M; Blay JY; Dutour A
BMC Cancer; 2023 Aug; 23(1):742. PubMed ID: 37563551
[TBL] [Abstract][Full Text] [Related]
13. Carbon-ion Radiotherapy for Inoperable Head and Neck Bone and Soft-tissue Sarcoma: Prospective Observational Study.
Musha A; Kubo N; Kawamura H; Okano N; Sato H; Okada K; Osu N; Yumisaki H; Adachi A; Takayasu Y; Shino M; Nikkuni O; Ida S; Shirai K; Saitoh JI; Yokoo S; Chikamatsu K; Ohno T
Anticancer Res; 2022 Mar; 42(3):1439-1446. PubMed ID: 35220237
[TBL] [Abstract][Full Text] [Related]
14. Bone sarcomas.
Alvegård T
Acta Oncol; 1996; 35 Suppl 7():123-4. PubMed ID: 9154104
[TBL] [Abstract][Full Text] [Related]
15. A risk factor analysis for local recurrence of bone and soft tissue sarcoma treated with carbon ion radiotherapy: A retrospective cohort study at a single institution.
Kohama I; Yanagawa T; Okamoto M; Ohno T; Chikuda H
Asia Pac J Clin Oncol; 2022 Aug; 18(4):434-440. PubMed ID: 34811886
[TBL] [Abstract][Full Text] [Related]
16. Systematic review of charged-particle therapy for chordomas and sarcomas of the mobile spine and sacrum.
Pennington Z; Ehresman J; Elsamadicy AA; Shin JH; Goodwin CR; Schwab JH; Sciubba DM
Neurosurg Focus; 2021 May; 50(5):E17. PubMed ID: 33932924
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of Carbon Ion Radiotherapy for Bone and Soft Tissue Sarcoma in Older Patients.
Kinoshita H; Yonemoto T; Yamada S; Imai R
Anticancer Res; 2024 Apr; 44(4):1773-1780. PubMed ID: 38537982
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas.
Kamada T; Tsujii H; Tsuji H; Yanagi T; Mizoe JE; Miyamoto T; Kato H; Yamada S; Morita S; Yoshikawa K; Kandatsu S; Tateishi A;
J Clin Oncol; 2002 Nov; 20(22):4466-71. PubMed ID: 12431970
[TBL] [Abstract][Full Text] [Related]
19. Developing an Evidence-based Followup Schedule for Bone Sarcomas Based on Local Recurrence and Metastatic Progression.
Cipriano C; Griffin AM; Ferguson PC; Wunder JS
Clin Orthop Relat Res; 2017 Mar; 475(3):830-838. PubMed ID: 27339121
[TBL] [Abstract][Full Text] [Related]
20. High control rates of proton- and carbon-ion-beam treatment with intensity-modulated active raster scanning in 101 patients with skull base chondrosarcoma at the Heidelberg Ion Beam Therapy Center.
Mattke M; Vogt K; Bougatf N; Welzel T; Oelmann-Avendano J; Hauswald H; Jensen A; Ellerbrock M; Jäkel O; Haberer T; Herfarth K; Debus J; Uhl M
Cancer; 2018 May; 124(9):2036-2044. PubMed ID: 29469932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
